Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2026 | Diagonal Therapeutics | $125.0M Series B | Janus Henderson Investors, Paulina Hill | Atlas Venture, Balyasny Asset Management, Biovision Ventures, BVF Partners, Checkpoint Capital, Deep Track Capital, EcoR1 Capital, Frazier Life Sciences, Lightspeed Venture Partners, Logos Capital, RA Capital Management, Velosity Capital, Viking Global Investors |
| Oct 1, 2025 | Valink Therapeutics | $12.0M Seed | Redalpine Venture Partners | Earlybird Venture Capital, Molten Ventures, Christian Wenger, Hoxton Ventures, LongeVC, Oxford Science Enterprises, p53 |
| Feb 4, 2025 | Akribion Therapeutics | $9.3M Seed | Carma Fund, RV Invest | — |
| Mar 14, 2024 | Asgard Therapeutics | $32.8M Series A | Johnson & Johnson Innovation, Aleksei Zeifman | Boehringer Ingelheim, Industrifonden, Joao Ribas |